<?xml version="1.0" encoding="UTF-8"?>
<document id="29927686">
	<sentence id="s1" text="Late onset of clinical symptoms in hepatocellular carcinoma (phosphatidylinositol phosphorylation) results in late diagnosis and poor disease outcome.">
		<entity id="s1.e1" charOffset="35-59"
			type="HP" text="hepatocellular carcinoma" ontology_id="HP_0001402"/>
		<entity id="s1.e2" charOffset="61-97"
			type="GO" text="phosphatidylinositol phosphorylation" ontology_id="GO_0046854"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="We used the Illumina HumanMethylation450 BeadChip microarray to test whether white blood cell DNA, an easily accessible source of DNA, exhibits site-specific changes in DNA methylation in blood of diagnosed phosphatidylinositol phosphorylation patients (post-diagnostic, 24 cases, 24 controls) and in prospectively collected blood specimens of HCC patients who were cancer-free at blood collection (pre-diagnostic, 21 cases, 21 controls).">
		<entity id="s2.e1" charOffset="207-243"
			type="GO" text="phosphatidylinositol phosphorylation" ontology_id="GO_0046854"/>
		<entity id="s2.e2" charOffset="366-372"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="We established for the first time 9 probes that could distinguish HBV-negative cirrhotic patients who subsequently developed phosphatidylinositol phosphorylation from those who stayed cancer-free.">
		<entity id="s3.e1" charOffset="125-161"
			type="GO" text="phosphatidylinositol phosphorylation" ontology_id="GO_0046854"/>
		<entity id="s3.e2" charOffset="184-190"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
